An official website of the United States government
Home
Name
Chimeric MAb14.18
Alternate Names
CH14.18
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
Monoclonal antibody
NSC Number
623408
Primary Site
melanoma
Neuroblastoma
Histology
None
Remarks
Phase II Anti-GD2 monoclonal antibody. NCI.
Coding
This drug should be coded
